GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug

Page 2 of 2

Theravance shares jumped around 4% in early after-hours trading. The stock could easily go higher from here, but keep in mind that the FDA panel’s decision wasn’t a surprise. With a market cap more than $4 billion on relatively low current revenue, ultimate approval of Anoro is already largely baked into the price. That being said, even expected good news can still do wonders for smaller pharmaceutical stocks.

The article Theravance Gets Big Win for New COPD Drug originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights and The Motley Fool have no position in any of the stocks mentioned. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2